NEVRO CORP's ticker is and the CUSIP is 64157FAA1. A total of 12 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,303,000 | +42.1% | 4,875,000 | +25.8% | 0.01% | +33.3% |
| Q2 2020 | $5,139,000 | -56.9% | 3,875,000 | -62.1% | 0.01% | -62.5% |
| Q1 2020 | $11,924,000 | -25.7% | 10,225,000 | -14.8% | 0.02% | +6.7% |
| Q4 2019 | $16,058,000 | +361.0% | 12,000,000 | +242.9% | 0.02% | +400.0% |
| Q3 2018 | $3,483,000 | +115.1% | 3,500,000 | +133.3% | 0.00% | +50.0% |
| Q2 2018 | $1,619,000 | +629.3% | 1,500,000 | +614.3% | 0.00% | – |
| Q4 2017 | $222,000 | -11.2% | 210,000 | 0.0% | 0.00% | – |
| Q3 2017 | $250,000 | -67.3% | 210,000 | -70.4% | 0.00% | -100.0% |
| Q2 2017 | $765,000 | -97.5% | 710,000 | -97.2% | 0.00% | -96.7% |
| Q1 2017 | $30,481,000 | +23.7% | 24,995,000 | +7.6% | 0.03% | +36.4% |
| Q4 2016 | $24,651,000 | +37.5% | 23,240,000 | +64.4% | 0.02% | +22.2% |
| Q3 2016 | $17,927,000 | – | 14,140,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 27,600,000 | $33,560,000 | 1.29% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,840,000 | $33,841,000 | 0.49% |
| Nicholas Investment Partners, LP | 5,530,000 | $6,692,000 | 0.47% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,625,000 | $27,455,000 | 0.43% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 15,650,000 | $19,064,000 | 0.36% |
| CAMDEN ASSET MANAGEMENT L P /CA | 9,275,000 | $11,223,000 | 0.29% |
| LINDEN ADVISORS LP | 1,751,000 | $2,130,000 | 0.08% |
| LORD, ABBETT & CO. LLC | 14,387,000 | $17,480,000 | 0.05% |
| AVIVA PLC | 4,500,000 | $5,468,000 | 0.03% |
| Allianz Asset Management GmbH | 24,995,000 | $30,481,000 | 0.03% |